Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Does Cannabis Alter REM/NREM Balance in OSA? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Sleep stage distribution is a key aspect of obstructive sleep apnoea (OSA), influencing restorative sleep and overall health. Investigating the impact of cannabis on REM NREM balance helps understand how cannabinoids may modify sleep architecture in OSA patients. 

Am I eligible for medical cannabis for pain relief?

Understanding Cannabis and Sleep Stages 

Cannabis can affect both REM and NREM sleep, potentially altering apnoea severity and sleep quality. Evaluating the impact of cannabis on REM NREM balance is essential for developing safe and effective therapeutic approaches. 

Influence on REM Sleep 

Cannabis effects on REM NREM suggest that certain cannabinoids may reduce REM sleep duration. This could be beneficial in OSA since apnoeic events are often more frequent during REM stages. 

Support for NREM Sleep 

By improving sleep stage distribution in OSA, cannabis may enhance deep NREM sleep, allowing for more restorative rest and fewer arousals caused by airway obstruction. 

Individual Variability 

The impact of cannabis on REM NREM balance can vary depending on the cannabinoid profile, dose, and patient-specific factors. Understanding cannabis effects on REM NREM can guide personalised interventions for OSA management. 

Evidence indicates that the impact of cannabis on REM NREM balance may improve sleep stage distribution in OSA by supporting NREM sleep and moderating REM periods, potentially reducing apnoea severity. Tailored dosing and cannabinoid selection remain important for optimal outcomes. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea . 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories